Value proposition

Raising the standards for real-world evidence generation to transform research and care for behavioral health

Holmusk is a data analytics and health technology company on a mission to harness real-world evidence to transform both research and care for behavioral health.

Combining a leading behavioral health database with AI-powered analytics and digital solutions designed to address the most pressing challenges in behavioral health, Holmusk is advancing the frontier of evidence generation and fueling innovation. Holmusk’s core offerings include HolCare EHR+, an electronic health records platform with built-in measurement-based care, and NeuroBlu Research, a powerful data analytics solution that enables users to build patient cohorts, explore datasets, and discover new insights.

Founded in 2015, Holmusk is a global company headquartered in Singapore and New York. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum.

Big Data, Information Technology, Health care, Machine learning, Predictive Analytics, digital health, data analytics, healthcare technology, behaviour change, employee benefit, Behavioral Health, Mental Health, Clinical Decision Support, Digital Therapeutics, Real-world Evidence, AI, Innovation, Pharma, Real-world Data, Electronic Health Records (EHRs), and Data harmonization